Breast cancer patients rarely present with isolated axillary lymph node metastasis without any clinical or radiological evidence of primary tumor. Identification of the primary site of tumor helps in planning appropriate patient management which has definite impact on patient's survival. We present here a case of 30-year-old female who presented with isolated right axillary lymph node metastasis with no evidence of primary tumor clinically. Conventional imaging modalities were negative for primary site. and it contributed significantly in early detection of occult primary tumor in right breast.
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Background
Breast cancer presenting as an isolated axillary lymph node metastasis with no clinical and radiological evidence of primary tumor is uncommon. The incidence is low ranging from 0.3-0.8% of all breast cancer patients [1] . American Joint Committee on Cancer has classified it as T0, N1-2, M0, Stage II-III [1] . Identification of primary site in such cases remains a challenge and has definite impact on patient's survival [1] . Clinical examination, noninvasive and invasive modalities like mammography, breast magnetic resonance imaging (MRI), ultrasound (USG), fine needle aspiration cytology (FNAC) and excision biopsy are used for diagnosis of primary site. The treatment of isolated axillary lymph node metastasis is controversial. Traditionally the choice of treatment for isolated axillary lymph node metastasis is mastectomy and axillary lymph node dissection [1, 2] . But in one third of patients histopathologic examination of the mastectomy specimen may not reveal the primary tumor [3, 4] . Hence there is clearly a need for noninvasive imaging modality for primary site detection to avoid unnecessary morbidity and for appropriate management. Here we report a case of 30-year-old female patient with isolated right axillary lymph node metastasis and unknown primary site in whom 
Case report
A 30-year-old female presented with right axillary lymphadenopathy. FNAC revealed metastatic carcinoma and excisional biopsy showed metastatic adenocarcinoma. She was extensively investigated for primary site. Conventional imaging modalities like mammography, non contrast enhanced CT chest and abdomen, USG neck and abdomen, upper gastrointestinal endoscopy showed no evidence of any primary site. 
Discussion
Breast cancer presenting as isolated axillary lymph node metastasis is an uncommon form of stage II disease and management becomes difficult without identification of primary site. Halsted first described two patients of occult primary breast cancer with axillary nodes involvement [2] . After axillary lymph node metastasis the time of appearance of primary breast tumor varies from 0.5 to 5 years [5] . Diagnostic and treatment protocols are not very well established. The prognosis for occult breast cancer with isolated axillary lymph nodes appears to be better than stage II palpable breast carcinoma. Hence the proper identification of primary site and appropriate management leads to good prognosis. Lymphoma is the most common malignant cause of axillary lymphadenopathy followed by breast carcinoma. More than 90% of patients with axillary lymph node metastasis have primary tumor in breast. Primary tumor from other sites like thyroid, lung, stomach, pancreas, ovary and colon can also metastasize to axillary lymph nodes, but they are less common [6] . In cases of occult breast cancer mammography, breast USG, CT and MRI are routinely used for primary tumor identification. The sensitivity of mammography is limited and varies from 0 to 56% percent for detection of occult primary site in breast. It may be due to dense breast parenchyma causing non visualization of small primary tumors. Contrast-enhanced CT and MRI has important role in primary site detection. But smaller non-enhancing lesions lesser than its resolution may be missed [7] . Morris et al. showed that contrast-enhanced MRI has an identification rate of 75% [8] . Orel et al. reported 86% sensitivity of breast MR imaging in identification of occult breast primary in patients with axillary lymph node metastasis [9] .
The role of 18 F-FDG PET/CT has also been evaluated. Takabatake et al. described that 18 F-FDG PET/CT was a helpful option for the diagnosis of primary sites in two cases of occult breast cancer where conventional imaging studies had difficulty in identifying [10] . Owaki et al. reported a case of 0.9 cm diameter primary breast carcinoma detected by FDG PET-CT [11] . It is a well-known fact that 18 F-FDG PET/CT as a functional tumor imaging modality, identifies the early pathological changes before obvious anatomical changes happen. Even though it is not routinely recommended for initial tumor and locoregional staging of breast cancer because of its reduced sensitivity, it is reported to be specific once the primary site is identified in cases of occult breast cancer. Walter et al. reported the sensitivity of MRI and PET-CT as 89 and 63%, and the specificity as 74 and 91%, respectively for primary breast tumor [12] .
18 F-FDG PET/CT can completely stage the disease which prognosticates the outcome and may identify other possible sites of primary tumors. In the above case with isolated right axillary lymph node metastasis 18 F-FDG PET/CT contributed significantly in early detection of occult primary in the right breast and it had an important impact on patient management. 
